Publication & Citation Trends
Publications
198 total
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
Cited by 40
Semantic Scholar
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.
Cited by 0
Semantic Scholar
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
Cited by 2
Semantic Scholar
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Cited by 13
Semantic Scholar
Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma.
Cited by 0
Semantic Scholar
Current development of chimeric antigen receptor T‐cell therapy for diffuse large B‐cell lymphoma and high‐grade B‐cell lymphoma OA
Cited by 6
Semantic Scholar
TCL-391 Valemetostat Monotherapy in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas: Primary Results From a Phase 1 Trial
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(45)
Reproductive System and Pregnancy
(34)
Reproductive Biology and Fertility
(31)
Circadian rhythm and melatonin
(26)
Sperm and Testicular Function
(18)
Affiliations
Chonnam National University
National Agriculture and Food Research Organization
Kyushu University
Chungnam National University
Tohoku University